Hutchmed (China) Limited

Share Issue/Capital Change • May 10, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4496E

Hutchison China Meditech Limited

10 May 2013

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Results of Annual General Meeting

London: Friday, 10 May 2013:Chi-Med today announces that all ordinary resolutions and special resolution put to its Annual General Meeting ("AGM") held on 10 May 2013 were duly passed.  The poll results of the resolutions were as follows:

		Number of Votes (%)*
Ordinary Resolutions		For	Against	Withheld
1	To consider and adopt the statement of audited accounts and the reports of the directors and independent auditor for the year ended 31 December 2012.	45,950,512              (99.893195%)	49,030 (0.106588%)	100 (0.000217%)
2(a)	To re-elect Mr Simon To as a director.	45,900,612 (99.784716%)	49,030 (0.106588%)	50,000 (0.108696%)
2(b)	To re-elect Mr Christian Hogg as a director.	45,999,642 (100%)	0 (0%)	0 (0%)
2(c)	To re-elect Mr Christian Salbaing as a director.	45,904,457 (99.793074%)	95,185 (0.206926%)	0 (0%)
3	To re-appoint PricewaterhouseCoopers as the auditor of the Company and authorise the board of directors to fix the auditor's remuneration.	45,999,442 (99.999565%)	200 (0.000435%)	0 (0%)
4(a)	Item 4(A) of the notice of the Meeting (To grant a general mandate to the directors of the Company to issue additional shares)	44,951,057 (97.720450%)	1,048,355 (2.279050%)	230 (0.000500%)
Special Resolution
4(b)	Item 4(B) of the notice of the Meeting (To disapply pre-emption rights)	43,649,342 (94.890612%)	2,350,300 (5.109388%)	0 (0%)
Ordinary Resolution
4(c)	Item 4(C) of the notice of the Meeting (To grant a general mandate to the directors of the Company to repurchase shares of the Company)	45,950,412 (99.892978%)	49,200 (0.106957%)	30 (0.000065%)

* Percentages rounded to 6 decimal places

As at the date of the AGM, the number of issued shares of Chi-Med was 52,051,448, which was the total number of shares entitling the holders to attend and vote on the ordinary resolutions and special resolution proposed at the AGM. 

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:     +852 2121 8200
Panmure Gordon (UK) Limited Richard Gray Andrew Potts Grishma Patel	Telephone:     +44 20 7886 2500
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:     +44 20 7638 9571 Mobile:             +44 7973 611 888 Mobile:             +44 7967 566 919

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSFEFFSFDSEEI